drugset / Trial / NCT06580041

Precision Care for Major Depressive Disorder

NCT06580041

Phase 4 Enrolling by invitation 150 enrolled University of California, San Francisco
RandomizedParallel-groupOpen-labelTreatment

Summary

This study aims to assess whether phenotyping-guided intervention selection is superior to intervention selection without phenotyping guidance (i.e., routine clinician and patient judgment regarding treatment selection) for depression.

Timeline

Start
2024-11-12
Primary completion
2029-09-01
Completion
2029-09-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Brexpiprazole Small molecule
Subject Guanfacine Small molecule
Subject Methylphenidate Small molecule
Subject Phenelzine Small molecule
Subject Pramipexole Unknown